| Term 
 
        | Hep C (HCV) is a ____________ virus |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug users HIV
 Blood transfusions < 1992
 Clotting factors < 1987
 Hemodialysis pts
 Healthcare workers via mucosal / needle exposure
 Non sterile tattoos
 Born 1945 - 1965
 Children born to mothers w/ HCV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Test for antibodies (anti-HCV) |  | 
        |  | 
        
        | Term 
 
        | HCV is detectable w/in __ - ___ weeks of exposure |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How many HCV genotypes?  Which is most common in U.S. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tx: genotype 1a/1b w/o cirrhosis |  | Definition 
 
        | daclatasvir + sofosbuvir X 12wk Ledipasvir/sofosbuvir X 12wk
 Simeprevir + sofosbuvir X 12wk
 Ombitasvir/paritaprevir/ritonavir + dasabuvir + RBV X 12wk (no RBV for genotype 1b)
 |  | 
        |  | 
        
        | Term 
 
        | Tx: genotype 1a/1b w/ cirrhosis |  | Definition 
 
        | Same as w/o but duration for most therapies incr to 24wks *Ledipasvir/sofosbuvir remains as 12wk duration
 ** Option to add RBV to daclatasvir + sofosbuvir regimen
 |  | 
        |  | 
        
        | Term 
 
        | Pearls: peginterferon alfa-2a + alpha-2b |  | Definition 
 
        | MOA: induces innate antiviral immune response Brand: Pegasys (a2a), Pegintron (a2b)
 Dosing: SQ INJ Qwk
 S/E: Flu-like, psyc, blood, thyroid, liver
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits replication of DNA (HBV) and RNA (HCV) Brand: Copegus (w/ a2a), Rebetol (w/ a2b)
 Dosing: PO
 * Req forms of birth control; cannot get preg for 6mo after tx ends
 **Never as monotherapy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits HCV replication by blocking NS3/4A protease inhibitor Brand: Olysio
 Dosing: PO
 S/E: photosensitivity
 *Do NOT use in pts w/ NS3 Q80K polymorphism
 **Sulfa drug
 ***not for monotherapy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA:blocks HCV replication by inhibiting NS5A protein Brand: Daklinza
 *3A4 substrate; P-gp inhibitor
 **Must be used with sofosbuvir
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits HCV replication by blocking NS5B RNA-dependent RNA polymerase Brand: Sovaldi
 *P-gp substrate
 **Avoid in pts also taking amiodorone (incr risk bradicardia)
 **Must use with RBV or PEG + RBV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ombitasvir/paritaprevir/ritonavir (must take w/ RBV) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ombitasvir/paritaprevir/ritonavir + dasabuvir (two tablets in pak) |  | 
        |  |